Get the Stockscreener App
14.94
2.35%
-0.36
After Hours:
15.26
0.32
+2.14%
Dariohealth Corp stock is traded at $14.94, with a volume of 39,437.
It is down -2.35% in the last 24 hours and up +110.13% over the past month.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
See More
Previous Close:
$15.30
Open:
$15.3
24h Volume:
39,437
Relative Volume:
0.66
Market Cap:
$33.99M
Revenue:
$20.35M
Net Income/Loss:
$-59.43M
P/E Ratio:
-14.50
EPS:
-1.03
Net Cash Flow:
$-30.96M
1W Performance:
-5.50%
1M Performance:
+110.13%
6M Performance:
+2.95%
1Y Performance:
-26.76%
1-Day Range:
$14.71
$15.98
1-Week Range:
$14.62
$16.55
52-Week Range:
$5.935
$31.00
Dariohealth Corp Stock (DRIO) Company Profile
Name
Dariohealth Corp
Sector
Industry
Phone
972-4-770-6377
Address
322 W 57TH ST. #33B, NEW YORK
Compare DRIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DRIO
Dariohealth Corp
|
14.94 | 87.03M | 20.35M | -59.43M | -30.96M | -1.03 |
|
VEEV
Veeva Systems Inc
|
286.09 | 46.97B | 2.97B | 809.93M | 1.33B | 4.8743 |
|
TEM
Tempus Ai Inc
|
94.47 | 16.75B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
67.50 | 12.29B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
93.23 | 7.80B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.16 | 6.81B | 906.14M | -52.62M | 89.62M | -0.3621 |
Dariohealth Corp Stock (DRIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-29-25 | Downgrade | TD Cowen | Buy → Hold |
| May-13-22 | Upgrade | Alliance Global Partners | Neutral → Buy |
| Apr-22-21 | Initiated | Cowen | Outperform |
| Mar-23-21 | Initiated | Stifel | Buy |
| Feb-25-21 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-01-21 | Downgrade | Alliance Global Partners | Buy → Neutral |
| Aug-17-20 | Initiated | Aegis Capital | Buy |
| Aug-29-17 | Initiated | Aegis Capital | Buy |
| May-09-16 | Initiated | Rodman & Renshaw | Buy |
View All
Dariohealth Corp Stock (DRIO) Latest News
Predicting DarioHealth Corp. trend using moving averagesWeekly Trade Analysis & Weekly High Conviction Ideas - newser.com
Combining price and volume data for DarioHealth Corp.July 2025 Recap & Precise Swing Trade Alerts - newser.com
How to use a screener to detect DarioHealth Corp. breakouts2025 Market Sentiment & Smart Investment Allocation Tips - newser.com
Dario Signs 6 New Employer Clients Representing Tens of Thousands of Lives Deepening its Leadership in Value-Based Care - PR Newswire
Real time pattern detection on DarioHealth Corp. stockPortfolio Performance Report & Daily Volume Surge Signals - newser.com
Candlestick signals on DarioHealth Corp. stock todayJuly 2025 News Drivers & Risk Managed Investment Strategies - newser.com
Should I hold or sell DarioHealth Corp. stock in 2025Dollar Strength & Growth Focused Investment Plans - newser.com
What earnings revisions data tells us about DarioHealth Corp.2025 Biggest Moves & Free Reliable Trade Execution Plans - newser.com
How strong is DarioHealth Corp. stock balance sheetShare Buyback & Verified Momentum Stock Ideas - newser.com
What’s next for DarioHealth Corp. stock priceInflation Watch & Verified Stock Trade Ideas - newser.com
Regression analysis insights on DarioHealth Corp. performanceRate Hike & Risk Managed Investment Entry Signals - newser.com
Is DarioHealth Corp. a candidate for recovery play2025 Dividend Review & Consistent Return Strategy Ideas - newser.com
Published on: 2025-10-09 06:39:29 - newser.com
Can momentum traders help lift DarioHealth Corp.Gap Down & Stock Timing and Entry Methods - newser.com
DarioHealth and OneStep Announce Strategic Collaboration to Integrate Smartphone-Only, Clinical-Grade Fall Risk Assessment Technology into Dario's Digital Health Multi-Condition Platform - Sahm
DarioHealth partners with OneStep to add fall risk assessment tech By Investing.com - Investing.com Canada
Is DarioHealth Corp a good long term investmentMerger & Acquisition Updates & Small Budget Capital Growth - earlytimes.in
DarioHealth partners with OneStep to add fall risk assessment tech - Investing.com
DarioHealth and OneStep announce collaboration to integrate smartphone-only fall risk assessment technology - MarketScreener
$50B Annual Fall Costs — DarioHealth Integrates OneStep's Smartphone Clinical-Grade Fall Risk Assessment - Stock Titan
Is DarioHealth Corp. stock poised for growthJuly 2025 Snapshot & Safe Capital Allocation Plans - newser.com
Is it time to cut losses on DarioHealth Corp.Share Buyback & Consistent Growth Equity Picks - newser.com
Can swing trading help recover from DarioHealth Corp. lossesJuly 2025 PreEarnings & AI Enhanced Trade Execution Alerts - newser.com
Tools to assess DarioHealth Corp.’s risk profile2025 Market Trends & AI Forecasted Entry and Exit Points - newser.com
Analyzing net buyer seller activity in DarioHealth Corp.Quarterly Performance Summary & Daily Chart Pattern Signals - newser.com
How sentiment analysis helps forecast DarioHealth Corp.Portfolio Risk Summary & Accurate Buy Signal Alerts - newser.com
Can DarioHealth Corp. stock sustain revenue growthQuarterly Investment Review & Low Risk Investment Opportunities - newser.com
2 Under-The-Radar Health-Tech Stocks With Surging Momentum Scores - Sahm
Is Himax Technologies Inc Depositary Receipt a good long term investmentStock Buy Signals & Low Entry Risk Stocks - earlytimes.in
Dariohealth Corp Stock (DRIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.29%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):